OmanDocSign in

Curriculum · Metabolic and Endocrine and Diabetes Mellitus

Thyroid nodule

Causes and risk

The symptoms more suggestive of malignancy are a rapidly enlarging swelling and hoarseness of voice.

The risk factors are a family history of thyroid malignancy or syndromes; a history of radiation exposure especially during childhood, or living near nuclear factories; male gender; age extremes; full body radiotherapy; and the syndromes Gardeners, Cowdens, Corney's and chromosomal translocation.

How it presents

Usually a solitary nodule palpated in the thyroid on routine physical examination, in a patient who denies pain, dysphagia, hoarseness and hemoptysis, and denies fatigue, weight change, heat or cold intolerance, diarrhea or constipation, with no family history of thyroid cancer. The history has to cover compressive, invasive and constitutional symptoms, and hyper or hypothyroid symptoms. A normal TSH does not end the evaluation.

How it is diagnosed

Check the TSH first, then image.

Three major things then set the next step: the size of the nodule, the US features suggestive of malignancy, and cervical lymphadenopathy. The ultrasound features that are highly suspicious for malignancy: heterogenous solid appearance, calcification, vascularity, irregular borders, large nodules, local compression, and suspicious lymphadenopathy.

The initial evaluation in all patients with a thyroid nodule, discovered either by palpation or noted incidentally on a radiologic procedure, is three things: history and physical examination; measurement of serum thyroid-stimulating hormone; and ultrasound to confirm the presence of nodularity, assess sonographic features, and assess for the presence of additional nodules and lymphadenopathy. If the serum TSH concentration is normal or elevated and the nodule meets sonographic criteria for sampling, then fine-needle aspiration biopsy is indicated.

Two worked cases sit on either side of the TSH. In a 62 year old woman incidentally found to have a 2-cm thyroid nodule on neck ultrasound whose thyroid-stimulating hormone is 4.8 mU/L in a range of 0.4-5.0, the most appropriate next step is fine-needle aspiration of the nodule, and not iodine uptake and scan, a free T4 level, no further investigations, or computed tomography of the neck. In a 78 year old woman with a 2-cm hypoechoic thyroid nodule who feels well, denies hoarseness, dysphagia and hyperthyroid symptoms, has never had head or neck radiation and has no family history of thyroid cancer, but whose thyroid-stimulating hormone is 0.1 mU/L, the most appropriate step is thyroid uptake and scan: the low TSH indicates high levels of thyroxine, free T4 or T3, suppressing it, and the most common diagnosis is a hyperfunctioning thyroid nodule, confirmed by that scan. There the low TSH at presentation indicates a low risk of the nodule being cancerous, so fine-needle aspiration is an unnecessary invasive test at this stage; a computed tomography scan is inappropriate with no family history of cancer and no radiation to the neck; repeating the ultrasound in 6 months will delay diagnosis; and measuring thyroid antibodies is more useful in diffuse enlargement of the thyroid.

And in a 42 year old woman with a solitary palpated nodule, no compressive or thyroid symptoms, no family history and a normal serum thyroid-stimulating hormone, the most appropriate next step in evaluation is ultrasonography and fine-needle aspiration, rather than a radionuclide scan, MRI or thyroid lobectomy.

The ultrasound features come as two groups, and the exam question is which group a feature belongs to.

Ultrasonographic features that are associated with an increased risk of thyroid cancer: hypoechoic; microcalcifications; twinkling on B-flow imaging; central vascularity; irregular margins; incomplete halo; nodule is taller than wide; documented enlargement of a nodule.

Ultrasonographic features that are associated with a low risk of thyroid cancer: hyperechoic; large, coarse calcifications, except medullary cancer; peripheral vascularity; resembles puff or Napoleon pastry; spongiform appearance; comet-tail shadowing.

Read the two groups against each other and they pair off, which is how they are held: it is the microcalcification and not the coarse calcification, the central and not the peripheral vascularity, and the hypoechoic and not the hyperechoic nodule that carry the risk. The one exception written into the low risk group is medullary cancer, where the large, coarse calcification does not reassure.